Literature DB >> 28841360

Prehospital End-tidal Carbon Dioxide Predicts Mortality in Trauma Patients.

Kelsey Childress, Kelly Arnold, Christopher Hunter, George Ralls, Linda Papa, Salvatore Silvestri.   

Abstract

BACKGROUND: End-tidal carbon dioxide (EtCO2) measurement has been shown to have prognostic value in acute trauma.
OBJECTIVE: Evaluate the association of prehospital EtCO2 and in-hospital mortality in trauma patients and to assess its prognostic value when compared to traditional vital signs.
METHODS: Retrospective, cross-sectional study of patients transported by a single EMS agency to a level one trauma center. We evaluated initial out-of-hospital vital signs documented by EMS personnel including EtCO2, respiratory rate (RR), systolic BP (SBP), diastolic BP (DBP), pulse (P), and oxygen saturation (O2) and hospital data. The main outcome measure was mortality.
RESULTS: 135 trauma patients were included; 9 (7%) did not survive. The mean age of patients was 40 (SD17) [Range 16-89], 97 (72%) were male, 76 (56%) were admitted to the hospital and 15 (11%) went to the ICU. The mean EtCO2 level was 18 mmHg (95%CI 9-28) [Range 5-41] in non-survivors compared to 34 mmHg (95%CI 32-35) [Range 11-51] in survivors. The area under the ROC curve (AUC) for EtCO2 in predicting mortality was 0.84 (0.67-1.00) (p = 0.001), RR was 0.82 (0.63-1.00), SBP was 0.72 (0.49-0.96), DBP was 0.72 (0.47-0.97), pulse was 0.51 (0.26-0.76), and O2 was 0.64 (0.37-0.91). Cut-off values at 30 mmHg yielded sensitivity = 89% (51-99), specificity = 68% (59-76), PPV = 13% (6-24) and NPV = 99% (93-100) for predicting mortality. There was no correlation between RR and EtCO2 (correlation 0.16; p = 0.06).
CONCLUSION: We found an inverse association between prehospital EtCO2 and mortality. This has implications for improving triage and assisting EMS in directing patients to an appropriate trauma center.

Entities:  

Keywords:  capnography; end-tidal carbon dioxide; prehospital; trauma; vital signs

Mesh:

Substances:

Year:  2017        PMID: 28841360     DOI: 10.1080/10903127.2017.1356409

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  6 in total

1.  Detection of exhaled methane levels for monitoring trauma-related haemorrhage following blunt trauma: study protocol for a prospective observational study.

Authors:  Péter Jávor; Ferenc Rárosi; Tamara Horváth; László Török; Endre Varga; Petra Hartmann
Journal:  BMJ Open       Date:  2022-07-06       Impact factor: 3.006

2.  Association of Ventilation during Initial Trauma Resuscitation for Traumatic Brain Injury and Post-Traumatic Outcomes: A Systematic Review.

Authors:  Mary Beth Howard; Nichole McCollum; Emily C Alberto; Hannah Kotler; Mary E Mottla; Laura Tiusaba; Susan Keller; Ivan Marsic; Aleksandra Sarcevic; Randall S Burd; Karen J O'Connell
Journal:  Prehosp Disaster Med       Date:  2021-05-31       Impact factor: 2.866

Review 3.  Applications of End-Tidal Carbon Dioxide (ETCO2) Monitoring in Emergency Department; a Narrative Review.

Authors:  Hamed Aminiahidashti; Sajad Shafiee; Alieh Zamani Kiasari; Mohammad Sazgar
Journal:  Emerg (Tehran)       Date:  2018-01-15

4.  Relationship between End-Tidal CO2 (ETCO2) and Lactate and their Role in Predicting Hospital Mortality in Critically Ill Trauma Patients; A Cohort Study.

Authors:  Elham Safari; Mehdi Torabi
Journal:  Bull Emerg Trauma       Date:  2020-04

5.  The effect of surgical masks on vital signs and EtCO2 in patients on oxygen therapy.

Authors:  Alten Oskay; Mehmet Uluturk; Hazan Cevirme; Tulay Oskay; Hande Senol; Mert Ozen; Murat Seyit; Atakan Yilmaz; Ibrahim Turkcuer
Journal:  Ir J Med Sci       Date:  2022-03-03       Impact factor: 1.568

6.  The utility of transcutaneous carbon dioxide measurements in the emergency department: A prospective cohort study.

Authors:  Mitchell Barneck; Linda Papa; Ashley Cozart; Kain Lentine; Jay Ladde; Linh Nguyen; Jeremy Mayfield; Josef Thundiyil
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.